Výsledky vyhledávání - Duygu Selcuklu
- Zobrazuji výsledky 1 - 18 z 18
-
1
MicroRNA-9 Inhibition of Cell Proliferation and Identification of Novel miR-9 Targets by Transcriptome Profiling in Breast Cancer Cells Autor S. Duygu Selçuklu, Mark T.A. Donoghue, Kristina Rehmet, Matheus de Souza Gomes, Antoine Fort, Prasad Kovvuru, Mohan Kumar Muniyappa, Michael J. Kerin, Anton J. Enright, Charles Spillane
Vydáno 2012Artigo -
2
Noninvasive Detection of Polyclonal Acquired Resistance to FGFR Inhibition in Patients With Cholangiocarcinoma Harboring FGFR2 Alterations Autor Anna M. Varghese, Juber Patel, Yelena Y. Janjigian, Fanli Meng, S. Duygu Selçuklu, Gopa Iyer, Brian Houck‐Loomis, James J. Harding, Eileen M. O’Reilly, Ghassan K. Abou‐Alfa, Maeve A. Lowery, Michael F. Berger
Vydáno 2021Artigo -
3
Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway Autor Maria M. Rubinstein, David M. Hyman, Imogen Caird, Helen Won, Krysten Soldan, Kenneth Seier, Alexia Iasonos, William P. Tew, Roisin E. O’Cearbhaill, Rachel N. Grisham, Martee L. Hensley, Tiffany A. Troso-Sandoval, Paul Sabbatini, Joyce Guillen, S. Duygu Selçuklu, Catherine Zimel, Jean Torrisi, Carol Aghajanian, Vicky Makker
Vydáno 2019Artigo -
4
Targeting Aurora B kinase prevents and overcomes resistance to EGFR inhibitors in lung cancer by enhancing BIM- and PUMA-mediated apoptosis Autor Kosuke Tanaka, Helena A. Yu, Shaoyuan Yang, Song Han, S. Duygu Selçuklu, Kwanghee Kim, Shriram Ramani, Yogesh Tengarai Ganesan, Allison Moyer, S. K. Sinha, Yuchen Xie, Kota Ishizawa, Hatice U. Osmanbeyoglu, Yang Lyu, Nitin Roper, Udayan Guha, Charles M. Rudin, Mark G. Kris, James J. Hsieh, Emily H. Cheng
Vydáno 2021Artigo -
5
Phase II Trial and Correlative Genomic Analysis of Everolimus Plus Bevacizumab in Advanced Non–Clear Cell Renal Cell Carcinoma Autor Martin H. Voss, Ana M. Molina, Ying‐Bei Chen, Kaitlin M. Woo, Joshua Chaim, Devyn Taylor Coskey, Almedina Redzematovic, Patricia Wang, William Lee, S. Duygu Selçuklu, Chung‐Han Lee, Michael F. Berger, Satish K. Tickoo, Victor E. Reuter, Sujata Patil, James J. Hsieh, Robert J. Motzer, Darren R. Feldman
Vydáno 2016Artigo -
6
Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid Autor Elena Pentsova, Ronak Shah, Jiabin Tang, Adrienne Boire, Daoqi You, Samuel Briggs, Antonio Omuro, Xuling Lin, Martin Fleisher, Christian Grommes, Katherine S. Panageas, Fanli Meng, S. Duygu Selçuklu, Shahiba Q. Ogilvie, Natalie M. DiStefano, Larisa Shagabayeva, Marc K. Rosenblum, Lisa M. DeAngelis, Agnès Viale, Ingo K. Mellinghoff, Michael F. Berger
Vydáno 2016Artigo -
7
Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma Autor James J. Hsieh, David Chen, Patricia I. Wang, Mahtab Marker, Almedina Redzematovic, Ying‐Bei Chen, S. Duygu Selçuklu, Nils Weinhold, Nancy Bouvier, Kety Huberman, Umesh Bhanot, Michael Chevinsky, Parul Patel, Patrizia Pinciroli, Helen Won, Daoqi You, Agnès Viale, William Lee, A. Ari Hakimi, Michael F. Berger, Nicholas D. Socci, Emily H. Cheng, Jennifer J. Knox, Martin H. Voss, Maurizio Voi, Robert J. Motzer
Vydáno 2016Artigo -
8
Resistance to TRK inhibition mediated by convergent MAPK pathway activation Autor Emiliano Cocco, Alison M. Schram, Amanda Kulick, Sandra Misale, Helen Won, Rona Yaeger, Pedram Razavi, Ryan Ptashkin, Jaclyn F. Hechtman, Eneda Toska, James Cownie, Romel Somwar, Sophie Shifman, Marissa S. Mattar, S. Duygu Selçuklu, Aliaksandra Samoila, Sean Guzman, Brian B. Tuch, Kevin Ebata, Elisa de Stanchina, Rebecca J. Nagy, Richard B. Lanman, Brian Houck‐Loomis, Juber Patel, Michael F. Berger, Marc Ladanyi, David M. Hyman, Alexander Drilon, Maurizio Scaltriti
Vydáno 2019Artigo -
9
Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid Autor Alexandra Miller, Ronak Shah, Elena Pentsova, Maryam Pourmaleki, Samuel Briggs, Natalie M. DiStefano, Youyun Zheng, Anna Skakodub, Smrutiben A. Mehta, Carl Campos, Wan-Ying Hsieh, S. Duygu Selçuklu, Lilan Ling, Fanli Meng, Xiaohong Jing, Aliaksandra Samoila, Tejus Bale, Dana W.Y. Tsui, Christian Grommes, Agnès Viale, Mark M. Souweidane, Viviane Tabar, Cameron Brennan, Anne S. Reiner, Marc K. Rosenblum, Katherine S. Panageas, Lisa M. DeAngelis, Robert J. Young, Michael F. Berger, Ingo K. Mellinghoff
Vydáno 2019Artigo -
10
The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers Autor Ezra Rosen, Helen Won, Youyun Zheng, Emiliano Cocco, Duygu Selcuklu, Yixiao Gong, Noah D. Friedman, Ino de Bruijn, S. Onur Sumer, Craig M. Bielski, Casey Savin, Caitlin Bourque, Christina J. Falcon, Nikeysha Clarke, Xiaohong Jing, Fanli Meng, Catherine Zimel, Sophie Shifman, Srushti Kittane, Fan Wu, Marc Ladanyi, Kevin Ebata, Jennifer Kherani, Barbara J. Brandhuber, James A. Fagin, Eric J. Sherman, Natasha Rekhtman, Michael F. Berger, Maurizio Scaltriti, David M. Hyman, Barry S. Taylor, Alexander Drilon
Vydáno 2022Artigo -
11
Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers Autor James J. Harding, Sarina A. Piha‐Paul, Ronak Shah, Jessica Murphy, James M. Cleary, Geoffrey I. Shapiro, David I. Quinn, Irene Braña, Víctor Moreno, Mitesh J. Borad, Sherene Loi, Iben Spanggaard, Haeseong Park, James M. Ford, Mónica Arnedos, Salomon M. Stemmer, Christelle de la Fouchardière, Christos Fountzilas, Jie Zhang, Daniel DiPrimeo, Casey Savin, S. Duygu Selçuklu, Michael F. Berger, Lisa D. Eli, Funda Meric‐Bernstam, Komal Jhaveri, David B. Solit, Ghassan K. Abou‐Alfa
Vydáno 2023Artigo -
12
Tumour lineage shapes BRCA-mediated phenotypes Autor Philip Jonsson, Chaitanya Bandlamudi, Michael L. Cheng, Preethi Srinivasan, Shweta S. Chavan, Noah D. Friedman, Ezra Rosen, Allison L. Richards, Nancy Bouvier, S. Duygu Selçuklu, Craig M. Bielski, Wassim Abida, Diana Mandelker, Ozge Ceyhan‐Birsoy, Liying Zhang, Ahmet Zehir, Mark T.A. Donoghue, José Baselga, Kenneth Offit, Howard I. Scher, Eileen M. O’Reilly, Zsofia K. Stadler, Nikolaus Schultz, Nicholas D. Socci, Agnès Viale, Marc Ladanyi, Mark E. Robson, David M. Hyman, Michael F. Berger, David B. Solit, Barry S. Taylor
Vydáno 2019Artigo -
13
Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase Inhibition Autor James J. Harding, Maeve A. Lowery, Alan H. Shih, Juan M. Schvartzman, Shengqi Hou, Christopher Famulare, Minal Patel, Mikhail Roshal, Richard Kinh Gian, Ahmet Zehir, Daoqi You, S. Duygu Selçuklu, Agnès Viale, Martin S. Tallman, David M. Hyman, Ed Reznik, Lydia W.S. Finley, Elli Papaemmanuil, Alessandra Tosolini, Mark G. Frattini, Kyle J. MacBeth, Guowen Liu, Bin Fan, Sung Choe, Bin Wu, Yelena Y. Janjigian, Ingo K. Mellinghoff, Luis A. Díaz, Ross L. Levine, Ghassan K. Abou‐Alfa, Eytan M. Stein, Andrew M. Intlekofer
Vydáno 2018Artigo -
14
AKT Inhibition in Solid Tumors With <i>AKT1</i> Mutations Autor David M. Hyman, Lillian M. Smyth, Mark T.A. Donoghue, Shannon N. Westin, Philippe L. Bédard, Emma Dean, Hideaki Bando, Anthony B. El-Khoueiry, José Alejandro Pérez Fidalgo, Alain C. Mita, Jan H.M. Schellens, Matthew T. Chang, Jonathan Reichel, Nancy Bouvier, S. Duygu Selçuklu, Tara E. Soumerai, Jean Torrisi, Joseph P. Erinjeri, Helen Ambrose, J. Carl Barrett, Brian Dougherty, Andrew Foxley, Justin P.O. Lindemann, Robert McEwen, Martin Pass, Gaia Schiavon, Michael F. Berger, Sarat Chandarlapaty, David B. Solit, Udai Banerji, José Baselga, Barry S. Taylor
Vydáno 2017Artigo -
15
Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients Autor Dana W.Y. Tsui, Michael L. Cheng, Maha Shady, Julie L. Yang, Dennis Stephens, Helen Won, Preethi Srinivasan, Kety Huberman, Fanli Meng, Xiaohong Jing, Juber Patel, Maysun Hasan, Ian Johnson, Erika Gedvilaite, Brian Houck‐Loomis, Nicholas D. Socci, S. Duygu Selçuklu, Venkatraman Seshan, Hongxin Zhang, Debyani Chakravarty, Ahmet Zehir, Ryma Benayed, Maria E. Arcila, Marc Ladanyi, Samuel A. Funt, Darren R. Feldman, Bob T. Li, Pedram Razavi, Jonathan E. Rosenberg, Dean F. Bajorin, Gopa Iyer, Wassim Abida, Howard I. Scher, Dana E. Rathkopf, Agnès Viale, Michael F. Berger, David B. Solit
Vydáno 2021Artigo -
16
Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer Autor Walid K. Chatila, Jin K. Kim, Henry Walch, Michael R. Marco, Chin‐Tung Chen, Fan Wu, Dana M. Omer, Danny N. Khalil, Karuna Ganesh, Xuan Qu, Anisha Luthra, Seo‐Hyun Choi, Yu-Jui Ho, Ritika Kundra, Katharine I. Groves, Oliver S. Chow, Andrea Cercek, Martin R. Weiser, Maria Widmar, Iris H. Wei, Emmanouil P. Pappou, Garrett M. Nash, Philip B. Paty, Qian Shi, Efsevia Vakiani, S. Duygu Selçuklu, Mark T.A. Donoghue, David B. Solit, Michael F. Berger, Jinru Shia, Raphael Pelossof, Paul B. Romesser, Rona Yaeger, J. Joshua Smith, Nikolaus Schultz, Francisco Sánchez-Vega, Julio García‐Aguilar
Vydáno 2022Artigo -
17
HER kinase inhibition in patients with HER2- and HER3-mutant cancers Autor David M. Hyman, Sarina A. Piha‐Paul, Helen Won, Jordi Rodón, Cristina Saura, Geoffrey I. Shapiro, Dejan Juric, David I. Quinn, Víctor Moreno, Bernard Doger, Ingrid A. Mayer, Valentina Boni, Emiliano Calvo, Sherene Loi, A. Craig Lockhart, Joseph P. Erinjeri, Maurizio Scaltriti, Gary A. Ulaner, Juber Patel, Jiabin Tang, Hannah Beer, S. Duygu Selçuklu, Aphrothiti J. Hanrahan, Nancy Bouvier, Myra Melcer, Rajmohan Murali, Alison M. Schram, Lillian M. Smyth, Komal Jhaveri, Bob T. Li, Alexander Drilon, James J. Harding, Gopa Iyer, Barry S. Taylor, Michael F. Berger, Richard E. Cutler, Feng Xu, Anna Butturini, Lisa D. Eli, Grace Mann, Cynthia Farrell, Alshad S. Lalani, Richard Bryce, Carlos L. Arteaga, Funda Meric‐Bernstam, José Baselga, David B. Solit
Vydáno 2018Artigo -
18
Efficacy and Determinants of Response to HER Kinase Inhibition in<i>HER2</i>-Mutant Metastatic Breast Cancer Autor Lillian M. Smyth, Sarina A. Piha‐Paul, Helen Won, Alison M. Schram, Cristina Saura, Sherene Loi, Janice Lu, Geoffrey I. Shapiro, Dejan Juric, Ingrid A. Mayer, Carlos L. Arteaga, Macarena I. de la Fuente, Adam M. Brufksy, Iben Spanggaard, Morten Mau‐Sørensen, Mónica Arnedos, Víctor Moreno, Valentina Boni, Joohyuk Sohn, Lee S. Schwartzberg, Xavier González, Andrés Cervantes, François‐Clément Bidard, Alexander N. Gorelick, Richard B. Lanman, Rebecca J. Nagy, Gary A. Ulaner, Sarat Chandarlapaty, Komal Jhaveri, Elena I. Gavrila, Catherine Zimel, S. Duygu Selçuklu, Myra Melcer, Aliaksandra Samoila, Yanyan Cai, Maurizio Scaltriti, Grace Mann, Feng Xu, Lisa D. Eli, Melanie Dujka, Alshad S. Lalani, Richard Bryce, José Baselga, Barry S. Taylor, David B. Solit, Funda Meric‐Bernstam, David M. Hyman
Vydáno 2019Artigo
Vyhledávací nástroje:
Související témata
Biology
Cancer
Cancer research
Medicine
Internal medicine
Gene
Genetics
Oncology
Biochemistry
Breast cancer
Mutation
Kinase
Targeted therapy
Apoptosis
Carcinogenesis
Cell biology
Mutant
PI3K/AKT/mTOR pathway
Receptor
Signal transduction
Somatic cell
Bioinformatics
Cancer cell
Cerebrospinal fluid
Chemotherapy
Clear cell renal cell carcinoma
Clinical endpoint
Clinical trial
Concordance
Enzyme